Long-Term Efficacy and Safety Results from a Phase 2 Study

Long-Term Efficacy and Safety Results from a Phase 2 Study

Long-Term Efficacy and Safety of Cilta-Cel in Patients With Relapsed/Refractory Multiple MyelomaПодробнее

Long-Term Efficacy and Safety of Cilta-Cel in Patients With Relapsed/Refractory Multiple Myeloma

Efficacy & Safety of On-Demand Vonoprazan Vs Placebo In the Treatment of Heartburn in NERD patients.Подробнее

Efficacy & Safety of On-Demand Vonoprazan Vs Placebo In the Treatment of Heartburn in NERD patients.

Efficacy and Safety of Pabinafusp-Alfa in MPS-II (Hunter Syndrome)Подробнее

Efficacy and Safety of Pabinafusp-Alfa in MPS-II (Hunter Syndrome)

Next Steps for PonatinibПодробнее

Next Steps for Ponatinib

Xavier Montalban, EAN 2020 – Long-term Phase II Outcomes of First Oral BTK Inhibitor in MSПодробнее

Xavier Montalban, EAN 2020 – Long-term Phase II Outcomes of First Oral BTK Inhibitor in MS

Clinical Implications of Late-Breaking Data on Disease Modifying Therapies for MS ManagementПодробнее

Clinical Implications of Late-Breaking Data on Disease Modifying Therapies for MS Management

U1 Intro to Pharm V5Подробнее

U1 Intro to Pharm V5

Актуальное